U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07104279) titled 'Z1 Hip System: Post-Market Clinical Follow Up Study' on July 29.
Brief Summary: The objectives of this study are to confirm the early to mid-term safety, performance, and clinical benefits of the Z1 Femoral Hip System in hemi-hip arthroplasty and primary total hip arthroplasty.
The primary objective of this post market clinical follow-up (PMCF) study is the assessment of safety by recording and analyzing the survival of the implant system at 2 years post-implantation. Safety will also be established by recording the incidence and frequency of revisions, complications, and adverse events. Relation of the events to implant, instrument...